2-Brom-xanthen-9-on | CAS:94994-62-4

We serve 2-Brom-xanthen-9-on CAS:94994-62-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Brom-xanthen-9-on

Chemical Name:2-Brom-xanthen-9-on
CAS.NO:94994-62-4
Synonyms:2-bromo-xanthen-9-one
2-bromo-9-phenylcarbazole
2-bromo-9H-xanthen-9-one
2-bromo-N-phenylcarbazole
9H-Xanthen-9-one,2-bromo
Molecular Formula:C18H12BrN
Molecular Weight:322.19900
 
Physical and Chemical Properties:
Boiling point:101ºC
Flash point:78ºC
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 2-Brom-xanthen-9-on chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9H-Xanthen-9-one,2-bromo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9H-Xanthen-9-one,2-bromo Use and application,2-bromo-xanthen-9-one technical grade,usp/ep/jp grade.


Related News: The Ministry of Agriculture said late Saturday that a fresh outbreak of a lethal form of influenza had been found in poultry in the southern province of Hunan, and that officials had ordered the slaughter of 17,828 chickens.2-Acetyl-3,5-dimethylpyrazine manufacturer International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.1,4-dichlorobenzene supplier Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.Cyanoacetic acid vendor Others wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production.